Cardlytics, Inc. CDLX
What this company does
Written from the business description in Cardlytics, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 4 March 2026. Every sentence was checked against that document before publication.
Revenue compounded at +2.6% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Each USD of equity lost 326 cents this year.
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 |
| Operating income $B | −0.1 | −0.2 | −0.1 | −0.5 | −0.1 | −0.1 | −0.0 | −0.0 | −0.0 | −0.1 |
| EBITDA $B | −0.1 | −0.2 | −0.1 | −0.4 | −0.1 | −0.0 | −0.0 | −0.0 | −0.0 | −0.1 |
| Income tax $B | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.1 | −0.2 | −0.1 | −0.5 | −0.1 | −0.1 | −0.0 | −0.1 | −0.0 | −0.1 |
| Free cash flow $B | 0.0 | −0.0 | −0.0 | −0.1 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −1.95 | −3.91 | −3.69 | −13.92 | −3.99 | −2.04 | −0.72 | −2.79 | −7.86 | −32.48 |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · |
| ROE % | −326.0 | −184.9 | −77.8 | −103.1 | −30.3 | −36.9 | −17.6 | · | · | · |
| Shares out B | 0.05 | 0.05 | 0.04 | · | · | · | · | 0.02 | 0.00 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Reconciled in 10 of 19 fiscal years. 38 checks could not be computed.